This challenge is exemplified by the cell-fate decisions that follow the exposure of normal or diseased cells to DNA damage, which culminate variously in damage repair, survival or death 5,6,11,15,16 . Ensemble analyses implicating the cell-death activating proteases Caspase-2, -3 and -9 in the mechanisms that dictate cell fate after DNA damage suggest that the apical activation of either Caspase-2 or -9 is instrumental 4,17-22 . In particular, Caspase-9 activation is proposed 3,4,17,23 to determine the therapeutic sensitivity of cancer cells to the genotoxic drug, cisplatin, which is widely used in the treatment of ovarian, lung and other common cancers 24 . Although there is growing evidence that non-genetic heterogeneity is a significant cause of therapeutic resistance to anticancer drugs including cisplatin 7,8 , underlying mechanisms that may open avenues to predict and potentially overcome resistance remain poorly characterized and difficult to model.Here, we report the development of a unique approach to monitor over time small biochemical networks in single living cells based on pairs of GFP-like fluorescent and non-fluorescent proteins (NyxBits), fast electronics and computational tools (NyxSense) of new design, a technology platform we will make available to the community. The NyxBits are a family of bright (reporter) and dark (quencher) GFP-like proteins that can be rationally combined to